Collaborative Exchange: Timing of Uridine Triacetate

Get Permission

The challenge of deciding when to administer uridine triacetate was explored by the panel.

Dr. Schwartzberg: I assume uridine triacetate would work more effectively if given very early; otherwise we would see the same kind of downstream toxicity we see with methotrexate.

Dr. Campen: Exactly, but this is difficult, because traditionally 5-FU has a very short half-life, about 5 to 10 minutes. The challenge is to know what the levels will be after infusion and to draw 5-FU levels and get a rapid turnaround time on those levels. In many cases, plasma 5-FU levels generally are < 0  ìg/L more than 3 hours after cessation of 5-FU dosing.

Dr. Schwartzberg: Are plasma 5-FU levels reliable in this setting? I would think that the drug works intracellularly, so they would not guide you very well.

Dr. Campen: If you start a continuous infusion by pump and look at plasma 5-FU levels, you do get a very reliable measurement of your AUC. But, at the same time, once you stop the pump, you also lose that very quickly too.

Ms. Vogel: So you should give uridine triacetate within the first 24 hours. If you have missed that 24-hour window, is it too late?

Dr. Campen: That is the unknown. The goal is to administer uridine triacetate within the first 24 hours, but it can be given up to 96 hours after 5-FU overdose per protocol.




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.